SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
How heart failure risk rises after surgery
Wed June 29th - The development of atrial fibrillation following surgery is an important risk factor for heart failure, researchers report today. More
Brain surgery benefits intracranial pressure
Wed June 29th - Craniectomy for intracranial hypertension offers significant benefit, according to new guidance, triggered by British research. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

Measures to prevent dementia 'cost-effective'

Wednesday October 21st 2020

Interventions for preventing dementia in England could be cost-effective, saving over a billion pounds per year, and could significantly reduce dementia rates, according to a new analysis.

A team from University College London, UK, looked at the potential economic value of a range of interventions to prevent late-onset dementia.

They examined previous studies of nine potentially modifiable risk factors. Results were published in The Lancet Healthy Longevity yesterday (20 October).

“We found effective interventions for hypertension, smoking cessation, diabetes prevention and hearing loss,” they write.

“Treatments for stopping smoking and provision of hearing aids reduced cost. Treatment of hypertension was cost-effective by reference to standard UK thresholds.”

They calculate that these three interventions, when fully implemented, would save £1.9bn annually in England and reduce dementia rate by 8.5%.

However, they found that the intervention for diabetes was unlikely to be cost-effective in terms of its impact on dementia.

They state: “There is a strong case for implementing the three effective interventions on grounds of cost-effectiveness and quality-of-life gains, as well as for improvements in general health.

“The interventions have the potential to remain cost-saving or cost-effective even with variations in dementia incidence and costs and effectiveness of interventions.”

Lead author Dr Naaheed Mukadam said: “It is becoming increasingly clear that dementia can be prevented in many cases by addressing various health factors throughout the lifespan. There is an urgent need to develop evidence-based interventions to prevent dementia or delay it to enable more years of healthy life.

“Here, we have found that dementia prevention strategies can be cost effective and cost saving and should be implemented to reduce the societal burden of dementia.”

Mukadam, N. et al. Effective interventions for potentially modifiable risk factors for late-onset dementia: a costs and cost-effectiveness modelling study. The Lancet Healthy Longevity 20 October 2020; doi: 10.1016/S2666-7568(20)30004-0

https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(20)30004-0/fulltext

Tags: Brain & Neurology | Pharmaceuticals | UK News

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES